190 related articles for article (PubMed ID: 32429377)
1. 1,2,4-Triazine Sulfonamides: Synthesis by Sulfenamide Intermediates, In Vitro Anticancer Screening, Structural Characterization, and Molecular Docking Study.
Branowska D; Karczmarzyk Z; Wolińska E; Wysocki W; Morawiak M; Urbańczyk-Lipkowska Z; Bielawska A; Bielawski K
Molecules; 2020 May; 25(10):. PubMed ID: 32429377
[TBL] [Abstract][Full Text] [Related]
2. Design, green synthesis, molecular docking and anticancer evaluations of diazepam bearing sulfonamide moieties as VEGFR-2 inhibitors.
Saleh NM; El-Gaby MSA; El-Adl K; Abd El-Sattar NEA
Bioorg Chem; 2020 Nov; 104():104350. PubMed ID: 33142416
[TBL] [Abstract][Full Text] [Related]
3. Design, Synthesis, In Vitro Anti-cancer Activity, ADMET Profile and Molecular Docking of Novel Triazolo[3,4-a]phthalazine Derivatives Targeting VEGFR-2 Enzyme.
El-Helby AA; Sakr H; Ayyad RRA; El-Adl K; Ali MM; Khedr F
Anticancer Agents Med Chem; 2018; 18(8):1184-1196. PubMed ID: 29651967
[TBL] [Abstract][Full Text] [Related]
4. In silico identification of novel inhibitors targeting the DNA-binding domain of the human estrogen receptor alpha.
Cao H; Sun Y; Wang L; Pan Y; Li Z; Liang Y
J Steroid Biochem Mol Biol; 2021 Oct; 213():105966. PubMed ID: 34416373
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and Characterization of New Series of 1,3-5-Triazine Hydrazone Derivatives with Promising Antiproliferative Activity.
H Al Rasheed HHA; M Malebari AM; A Dahlous KA; El-Faham A
Molecules; 2020 Jun; 25(11):. PubMed ID: 32545272
[TBL] [Abstract][Full Text] [Related]
6. Review of the Synthesis and Anticancer Properties of Pyrazolo[4,3-
Bernat Z; Szymanowska A; Kciuk M; Kotwica-Mojzych K; Mojzych M
Molecules; 2020 Aug; 25(17):. PubMed ID: 32872493
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis, biological evaluation and molecular docking studies of novel 3-aryl-4-anilino-2H-chromen-2-one derivatives targeting ERα as anti-breast cancer agents.
Luo G; Chen M; Lyu W; Zhao R; Xu Q; You Q; Xiang H
Bioorg Med Chem Lett; 2017 Jun; 27(12):2668-2673. PubMed ID: 28460819
[TBL] [Abstract][Full Text] [Related]
8. New pyrazolo[4,3-e][1,2,4]triazine sulfonamides as carbonic anhydrase inhibitors.
Mojzych M; Ceruso M; Bielawska A; Bielawski K; Fornal E; Supuran CT
Bioorg Med Chem; 2015 Jul; 23(13):3674-80. PubMed ID: 25921266
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and kinase inhibitory activity of new sulfonamide derivatives of pyrazolo[4,3-e][1,2,4]triazines.
Mojzych M; Šubertová V; Bielawska A; Bielawski K; Bazgier V; Berka K; Gucký T; Fornal E; Kryštof V
Eur J Med Chem; 2014 May; 78():217-24. PubMed ID: 24681986
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis and in vitro anticancer evaluation of 4,6-diamino-1,3,5-triazine-2-carbohydrazides and -carboxamides.
Kothayer H; Elshanawani AA; Abu Kull ME; El-Sabbagh OI; Shekhar MP; Brancale A; Jones AT; Westwell AD
Bioorg Med Chem Lett; 2013 Dec; 23(24):6886-9. PubMed ID: 24153206
[TBL] [Abstract][Full Text] [Related]
11. Di- and tri-substituted s-triazine derivatives: Synthesis, characterization, anticancer activity in human breast-cancer cell lines, and developmental toxicity in zebrafish embryos.
El-Faham A; Farooq M; Almarhoon Z; Alhameed RA; Wadaan MAM; de la Torre BG; Albericio F
Bioorg Chem; 2020 Jan; 94():103397. PubMed ID: 31706684
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and molecular modeling studies of new series of antitumor 1,2,4-triazines with potential c-Met kinase inhibitory activity.
El-Wakil MH; Ashour HM; Saudi MN; Hassan AM; Labouta IM
Bioorg Chem; 2018 Feb; 76():154-165. PubMed ID: 29175587
[TBL] [Abstract][Full Text] [Related]
13. SAR study of tyrosine-chlorambucil hybrid regioisomers; synthesis and biological evaluation against breast cancer cell lines.
Descôteaux C; Brasseur K; Leblanc V; Parent S; Asselin E; Bérubé G
Amino Acids; 2012 Aug; 43(2):923-35. PubMed ID: 22102055
[TBL] [Abstract][Full Text] [Related]
14. Design and synthesis of mono-and di-pyrazolyl-s-triazine derivatives, their anticancer profile in human cancer cell lines, and in vivo toxicity in zebrafish embryos.
Farooq M; Sharma A; Almarhoon Z; Al-Dhfyan A; El-Faham A; Taha NA; Wadaan MAM; Torre BG; Albericio F
Bioorg Chem; 2019 Jun; 87():457-464. PubMed ID: 30927586
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, Anti-Breast Cancer Activity, and Molecular Docking Study of a New Group of Acetylenic Quinolinesulfonamide Derivatives.
Marciniec K; Pawełczak B; Latocha M; Skrzypek L; Maciążek-Jurczyk M; Boryczka S
Molecules; 2017 Feb; 22(2):. PubMed ID: 28212337
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis, docking studies and biological evaluation of novel dihydro-1,3,5-triazines as human DHFR inhibitors.
Zhou X; Lin K; Ma X; Chui WK; Zhou W
Eur J Med Chem; 2017 Jan; 125():1279-1288. PubMed ID: 27886545
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and biological evaluation of novel carbohydrate-based sulfonamide derivatives as antitumor agents.
Hao S; Cheng X; Wang X; An R; Xu H; Guo M; Li C; Wang Y; Hou Z; Guo C
Bioorg Chem; 2020 Nov; 104():104237. PubMed ID: 32911194
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, Antitumor Evaluation, Molecular Modeling and Quantitative Structure-Activity Relationship (QSAR) of Novel 2-[(4-Amino-6-
Tomorowicz Ł; Sławiński J; Żołnowska B; Szafrański K; Kawiak A
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32331219
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and in vitro anticancer evaluation of some 4,6-diamino-1,3,5-triazine-2-carbohydrazides as Rad6 ubiquitin conjugating enzyme inhibitors.
Kothayer H; Spencer SM; Tripathi K; Westwell AD; Palle K
Bioorg Med Chem Lett; 2016 Apr; 26(8):2030-4. PubMed ID: 26965855
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and molecular docking of some novel anticancer sulfonamides carrying a biologically active pyrrole and pyrrolopyrimidine moieties.
Ghorab MM; Alsaid MS; Nissan YM
Acta Pol Pharm; 2014; 71(4):603-14. PubMed ID: 25272886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
